Back
Black Diamond Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
BDTX
Black Diamond Therapeutics
Last Price:
2.55
Seasonality Move:
28.2%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Black Diamond Therapeutics Price Quote
$2.55
+0.01 (+4.94%)
(Updated: November 23, 2024 at 5:26 AM ET)
Black Diamond Therapeutics Key Stats
Sell
40
Black Diamond Therapeutics (BDTX)
is a Sell
Day range:
$2.40 - $2.62
52-week range:
$2.16 - $7.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.48%
Volume:
598.8K
Avg. volume:
599.9K
1-year change:
8.55%
Market cap:
$143.7M
Revenue:
$0
EPS:
$-1.33
How Much Does Black Diamond Therapeutics Make?
Data Unavailable
Is Black Diamond Therapeutics Growing As A Company?
Data Unavailable
Black Diamond Therapeutics Stock Price Performance
-
Did Black Diamond Therapeutics Stock Go Up Last Month?
Black Diamond Therapeutics share price went down by -23.26% last month -
Did BDTX's Share Price Rise Over The Last Year?
BDTX share price rose by 8.55% over the past 1 year
What Is Black Diamond Therapeutics 52-Week High & Low?
-
What Is Black Diamond Therapeutics’s 52-Week High Share Price?
Black Diamond Therapeutics has traded as high as $7.66 over the past 52 weeks -
What Is Black Diamond Therapeutics’s 52-Week Low Share Price?
Black Diamond Therapeutics has traded as low as $2.16 over the past 52 weeks
Black Diamond Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Black Diamond Therapeutics?
-
How Much Debt Does Black Diamond Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Black Diamond Therapeutics Have?
Cash and short term investments quarterly total is $112.7M -
What Is Black Diamond Therapeutics’s Book Value Per Share?
Book value per share is 1.72
Is Black Diamond Therapeutics Cash Flow Positive?
-
What Is BDTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$61.2M -
What Is Black Diamond Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25.2M -
What Is Black Diamond Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $1.4M
Black Diamond Therapeutics Return On Invested Capital
Data Unavailable
Black Diamond Therapeutics Earnings Date & Stock Price
-
What Is Black Diamond Therapeutics's Stock Price Today?
A single share of BDTX can be purchased today for 2.54 -
What Is Black Diamond Therapeutics’s Stock Symbol?
Black Diamond Therapeutics trades on the nasdaq under the ticker symbol: BDTX -
When Is Black Diamond Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Black Diamond Therapeutics is scheduled on March 12, 2025 -
When Is BDTX's next ex-dividend date?
Black Diamond Therapeutics's next ex-dividend date is November 25, 2024 -
How To Buy Black Diamond Therapeutics Stock?
You can buy Black Diamond Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Black Diamond Therapeutics Competitors
-
Who Are Black Diamond Therapeutics's Competitors?
Below is a list of companies who compete with Black Diamond Therapeutics or are related in some way:
Black Diamond Therapeutics Dividend Yield
-
What Is BDTX Dividend Yield?
Black Diamond Therapeutics’s dividend yield currently is 0% -
What Is Black Diamond Therapeutics’s Payout Ratio?
Black Diamond Therapeutics’s payout ratio is 0% -
When Did Black Diamond Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is Black Diamond Therapeutics’s Dividend Per Share?
Black Diamond Therapeutics pays a dividend of $0.00 per share
Black Diamond Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 21.5% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 14.50 |
| Upside from Last Price: | 470.87% |